Zuga Matt (CIK 1790214) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-23). Recent activity: Sell ABOS (2,473 shares), Sell ABOS (1,687 shares), Buy ABOS (99,133 shares), Sell ABOS (6,888 shares), Sell ABOS (4,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-23 | Acumen Pharmaceuticals, Inc. (ABOS) | CFO & Chief Business Officer | Sell | 2,473 | $4,476 |
| 2026-01-23 | Acumen Pharmaceuticals, Inc. (ABOS) | CFO & Chief Business Officer | Sell | 1,687 | $3,138 |
| 2026-01-21 | Acumen Pharmaceuticals, Inc. (ABOS) | CFO & Chief Business Officer | Buy | 99,133 | $0 |
| 2026-01-12 | Acumen Pharmaceuticals, Inc. (ABOS) | CFO & Chief Business Officer | Sell | 6,888 | $12,536 |
| 2026-01-07 | Acumen Pharmaceuticals, Inc. (ABOS) | CFO & Chief Business Officer | Sell | 4,000 | $7,840 |
| 2026-01-07 | Acumen Pharmaceuticals, Inc. (ABOS) | CFO & Chief Business Officer | Sell | 5,100 | $10,047 |
| 2026-01-07 | Acumen Pharmaceuticals, Inc. (ABOS) | CFO & Chief Business Officer | Sell | 4,105 | $8,210 |
| 2026-01-07 | Acumen Pharmaceuticals, Inc. (ABOS) | CFO & Chief Business Officer | Sell | 1,700 | $3,383 |
来源：SEC Form 4 申报文件 · 截至 2026-01-23